40 related articles for article (PubMed ID: 27734522)
21. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
Hamadeh F; MacNamara SP; Aguilera NS; Swerdlow SH; Cook JR
Mod Pathol; 2015 Apr; 28(4):564-74. PubMed ID: 25216226
[TBL] [Abstract][Full Text] [Related]
22. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.
Xu L; Hunter ZR; Yang G; Zhou Y; Cao Y; Liu X; Morra E; Trojani A; Greco A; Arcaini L; Varettoni M; Brown JR; Tai YT; Anderson KC; Munshi NC; Patterson CJ; Manning RJ; Tripsas CK; Lindeman NI; Treon SP
Blood; 2013 Mar; 121(11):2051-8. PubMed ID: 23321251
[TBL] [Abstract][Full Text] [Related]
23. Waldenström macroglobulinemia.
Treon SP; Hunter ZR; Castillo JJ; Merlini G
Hematol Oncol Clin North Am; 2014 Oct; 28(5):945-70. PubMed ID: 25212891
[TBL] [Abstract][Full Text] [Related]
24. Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.
Kapoor P; Paludo J; Ansell SM
Curr Treat Options Oncol; 2016 Mar; 17(3):16. PubMed ID: 26942591
[TBL] [Abstract][Full Text] [Related]
25. Are you sure this is Waldenstrom macroglobulinemia?
Ghobrial IM
Hematology Am Soc Hematol Educ Program; 2012; 2012():586-94. PubMed ID: 23233639
[TBL] [Abstract][Full Text] [Related]
26. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
Magro CM; Yang A; Fraga G
Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
[TBL] [Abstract][Full Text] [Related]
27. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
[TBL] [Abstract][Full Text] [Related]
28. Persistent polyclonal B-cell lymphocytosis.
Agrawal S; Matutes E; Voke J; Dyer MJ; Khokhar T; Catovsky D
Leuk Res; 1994 Oct; 18(10):791-5. PubMed ID: 7934138
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of Memory Marginal Zone B Cells.
Hendricks J; Bos NA; Kroese FGM
Crit Rev Immunol; 2018; 38(2):145-158. PubMed ID: 29887727
[TBL] [Abstract][Full Text] [Related]
30. Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies-A Systematic Review.
Cox MC; Esposito F; Postorino M; Venditti A; Di Napoli A
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760410
[TBL] [Abstract][Full Text] [Related]
31. Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).
Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Roumelioti M; Sachanas S; Korkolopoulou P; Koulieris E; Moschogiannis M; Yiakoumis X; Tsirkinidis P; Pontikoglou C; Rondoyianni D; Papadaki HA; Panayiotidis P; Angelopoulou MK
Hematol Oncol; 2017 Dec; 35(4):542-547. PubMed ID: 27734522
[TBL] [Abstract][Full Text] [Related]
32. Clonal B-cell lymphocytosis of marginal zone origin.
Xochelli A; Oscier D; Stamatopoulos K
Best Pract Res Clin Haematol; 2017; 30(1-2):77-83. PubMed ID: 28288720
[TBL] [Abstract][Full Text] [Related]
33.
Yu X; Li W; Deng Q; Li L; Hsi ED; Young KH; Zhang M; Li Y
Cancer Res; 2018 May; 78(10):2457-2462. PubMed ID: 29703722
[TBL] [Abstract][Full Text] [Related]
34. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.
Swerdlow SH; Kuzu I; Dogan A; Dirnhofer S; Chan JK; Sander B; Ott G; Xerri L; Quintanilla-Martinez L; Campo E
Virchows Arch; 2016 Mar; 468(3):259-75. PubMed ID: 26454445
[TBL] [Abstract][Full Text] [Related]
35. Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.
Baloda V; Wheeler SE; Murray DL; Kohlhagen MC; Vos JA; Yatsenko SA; Agha ME; Djokic M; Swerdlow SH; Bailey NG
Diagn Pathol; 2022 Aug; 17(1):63. PubMed ID: 35932039
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]